Παρακολούθηση
Ranjit Manchanda
Ranjit Manchanda
Professor of Gynaecological Oncology and Consultant Gynaecological Oncologist
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα qmul.ac.uk
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ...
The Lancet 397 (10290), 2182-2193, 2021
5842021
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort
I Jacobs, A Gentry-Maharaj, M Burnell, R Manchanda, N Singh, A Sharma, ...
The lancet oncology 12 (1), 38-48, 2011
2942011
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
EJ Crosbie, NAJ Ryan, MJ Arends, T Bosse, J Burn, JM Cornes, ...
Genetics in Medicine 21 (10), 2390-2400, 2019
2352019
Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: a randomized controlled trial
MM Mäenpää, K Nieminen, EI Tomás, M Laurila, TH Luukkaala, ...
American journal of obstetrics and gynecology 215 (5), 588. e1-588. e7, 2016
2082016
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial
R Manchanda, K Loggenberg, S Sanderson, M Burnell, J Wardle, ...
Journal of the National Cancer Institute 107 (1), dju379, 2015
2022015
Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study
AN Rosenthal, LSM Fraser, S Philpott, R Manchanda, M Burnell, ...
Journal of Clinical Oncology 35 (13), 1411-1420, 2017
1992017
Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women
R Manchanda, S Patel, VS Gordeev, AC Antoniou, S Smith, A Lee, ...
JNCI: Journal of the National Cancer Institute 110 (7), 714-725, 2018
1982018
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history–based testing
R Manchanda, R Legood, M Burnell, A McGuire, M Raikou, K Loggenberg, ...
Journal of the National Cancer Institute 107 (1), dju380, 2015
1952015
Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule
AN Rosenthal, L Fraser, R Manchanda, P Badman, S Philpott, J Mozersky, ...
Journal of Clinical Oncology 31 (1), 49-57, 2013
1772013
Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status
R Manchanda, A Abdelraheim, M Johnson, AN Rosenthal, E Benjamin, ...
BJOG: An International Journal of Obstetrics & Gynaecology 118 (7), 814-824, 2011
1632011
A cost-effectiveness analysis of multigene testing for all patients with breast cancer
L Sun, A Brentnall, S Patel, DSM Buist, EJA Bowles, DGR Evans, ...
JAMA oncology 5 (12), 1718-1730, 2019
1392019
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: a systematic review and meta-analysis of individual patient data
PA Cohen, A Powell, S Böhm, CB Gilks, CJR Stewart, TM Meniawy, ...
Gynecologic oncology 154 (2), 441-448, 2019
1092019
Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II
MHM Oonk, B Slomovitz, PJW Baldwin, HC Van Doorn, J Van der Velden, ...
Journal of Clinical Oncology 39 (32), 3623-3632, 2021
1072021
Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis
R Manchanda, M Burnell, A Abdelraheim, M Johnson, A Sharma, ...
BJOG: An International Journal of Obstetrics & Gynaecology 119 (5), 527-536, 2012
812012
Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome
A Kriplani, R Manchanda, N Agarwal, B Nayar
The Journal of the American Association of Gynecologic Laparoscopists 8 (4 …, 2001
802001
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry
R Manchanda, S Patel, AC Antoniou, E Levy-Lahad, C Turnbull, ...
American journal of obstetrics and gynecology 217 (5), 578. e1-578. e12, 2017
792017
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects
S Jervis, H Song, A Lee, E Dicks, P Harrington, C Baynes, R Manchanda, ...
Journal of Medical Genetics 52 (7), 465-475, 2015
782015
Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’for ovarian cancer prevention: a cost-effectiveness analysis
R Manchanda, R Legood, AC Antoniou, VS Gordeev, U Menon
Journal of medical genetics 53 (9), 591-599, 2016
752016
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
R Manchanda, L Sun, S Patel, O Evans, J Wilschut, AC De Freitas Lopes, ...
Cancers 12 (7), 1929, 2020
692020
Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS)
R Manchanda, E Saridogan, A Abdelraheim, M Johnson, AN Rosenthal, ...
Archives of gynecology and obstetrics 286, 1555-1562, 2012
682012
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20